DAFTAR PUSTAKA

1. Pokja Infeksi Perhimpunan Dokter Paru Indonesia. Pneumonia Komunitas:

Pedoman Diagnosis dan Penatalaksanaan Di Indonesia. 2003
2. Bartlett JG, Scott F, Dowell, Lionel A, Mandell, et al. Practice Guidelines for
the Management of Community-Acquired Pneumonia in Adults. Clinical
Infectious Diseases. 2000; 31: 347–82
3. South East Asian Medical Information Center. Seamic health statistics 2000.
2001
4. Mongardon N, Max A, Bougle A, Pene F, Lemiale V, Charpentier J, et al.
Epidemiology and outcome of severe pneumococcal pneumonia admitted to
intensive care unit: a multicenter study. Critical care. 2012; 16(4): R155
5. WHO. Pneumonia. 2014. Available from:
www.who.int/mediacentre/factsheets/fs331/en/
6. Musher DM, Anna R. Thorner. Community-Acquired Pneumonia. The New
England Journal Of Medicine. 2014: 371; 17
7. File TM. Community-Acquired Pneumonia. Lancet. 2003: 362; 1991

8. Brown JS. Community-Acquired Pneumonia. Clinical Medicine 2012, Vol

12, No 6: 538–543

9. Dharmadhikari V, Joseph T, Kulkarni A. Bacteriological and Clinical Profile

of Community Acquired Pneumonia in Hospitalized Patients. International
Journal of Pharma and Bio Sciences. 2013: 695–702

10. Farida H, Juliëtte A. Severin, M. Gasem MH, et al. Nasopharyngeal Carriage

of Klebsiella pneumoniae and Other Gram-Negative Bacilli in Pneumonia-
Prone Age Groups in Semarang, Indonesia. Journal of Clinical Microbiology.
2013: 1614–1616

11. Lim WS, Eerden MM, Laing R, et al. Defining community acquired
pneumonia severity on presentation to hospital: an international derivation
and validation study. Thorax. 2003; 58: 377–382

48
 49

12. Lawrence MT, McPhee JS, Papadakis AM. Diagnosis dan Terapi Kedokteran
Penyakit Dalam. 1 ed. Jakarta: Salemba Medika; 2002. 100 - 10 p
13. Armitage K, Woodhead M. New guidelines for the management of adult
community-acquired pneumonia. Current opinion in infectious diseases.
2007; 20(2): 170-6
14. Dahlan Z. Chapter Pneumonia in Buku Ajar Penyakit Dalam jilid II Edisi IV.
Jakarta: Interna Publishing: 2014. 1608-1619
15. WHO. Pneumonia. 2014. Available from:
who.int/mediacentre/factsheets/fs310/en/
16. Mendel LA, Wuderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC,
Dowell SF, et al. Infectious Disease Society Of America / American Thoracic
Society Consensus Guidelines On The Management Of Community-Acquired
Pneumonia In Adults. Clinical Infectious Disease. 2007; 44: 527-72
17. Ewig S, Welte T. Evaluation of guidelines for community-acquired
pneumonia: a story of confounders, surprises and challenges. Eur Respir J.
2008; 32: 823-5
18. Rabbat A, Huchon GJ. Bacterial Pneumonia. Dalam: Albert RK, Spiro SG,
Jett JR, Clinical Respiratory Medicine, second edition. Ontario: Mosby. 2004;
23: 273-287
19. Mandell LA, Bartlett JG, Dowell SF, File TM Jr, Musher DM, Whitney C.
Infectious Diseases Society of America. Update of practice guidelines for the
management of community-acquired pneumonia in immunocompetent adults.
Clin Infect Dis. 2003; 37: 1405-1433
20. CDC. The Pink Book: Course Textbook - 12th Edition Second Printing. May
2012. Available from: cdc.gov/vaccines/pubs/pinkbook/pneumo.html
21. Lim WS, Macfarlane JT, Boswell TCJ, Harrison TG, Rose D, Leinonen M,
Saikku P. Study of community acquired pneumonia aetiology (SCAPA) in
adults admitted to hospital: implication for management guidelines. Thorax
2001; 56: 296 – 301
 50

22. Sharpe BA, Flanders SA. Community Acquired Pneumonia: A practical

approach to management for hospital. Journal of Hospital Medicine vol 1, no
3. 2006; 177-190
23. Mandell LA. Pneumonia, In : Fauci AS, Kasper DL, Longo DL, eds,
Harrison’s Principles of Internal Medicine, 17th ed, USA, The Mc Graw- Hill
companies Inc. 2008; chapter 251
24. Sharma S, Maycher Bruce, Eschun Gregg. Radiological Imaging in
Pneumonia. Recent Innovations Imaging of Bacterial Pneumonia; 2014.
Available from: medscape.org/viewarticle/556344_2
25. Boersma WG, Daniels J, Löwenberg A, Boeve W-J, van de Jagt EJ.
Reliability of radiographic findings and the relation to etiologic agents in
community-acquired pneumonia. Respiratory medicine. 2006; 100(5): 926-
32
26. Mandell LA, Wunderink R. Pneumonia. Harrison's Principles of Internal
Medicine. 2. 18th Edition ed. Jakarta: Penerbit Buku Kedokteran EGC. 2006.
957 – 90 p
27. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al.
A prediction rule to identify low-risk patients with community-acquired
pneumonia.N Engl J Med 1997; 336: 243–50

28. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell
GD, et al; American Thoracic Society. Guidelines for the management of
adults with community-acquired pneumonia: Diagnosis, assessment of
severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med.
2001; 163: 1730-1754.
29. Blot SI, Rodriguez A, Solé-Violán, J, Blanquer J, Almirall J, and Rello J.
Effects of delayed oxygenation assessment on time to antibiotic delivery and
mortality in patients with severe community-acquired pneumonia. Crit Care
Med 2007; 35: 2509–2514
30. Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I, et al.
BTS guidelines for the management of community acquired pneumonia in
 51

adults: update 2009. Thorax 2009; 64: iii1- iii55 doi: 10.1136/thx. 2009.
121434
31. Nair V, Niederman MS, Masani N, Fishbane S. Hyponatremia in community-
acquired pneumonia. Mineola. American Journal of Nephrology. 2007;
27(2):184-190
32. Prasad R. Community Acquired Pneumonia: Clinical Manifestations. Uttar
Pradesh. Supplement to JAPI 2012 VOL. 60: 10
33. Yamakawa S, et al. Recurrent Pneumonia with Unconsciousness. Yokohama,
Japan. Journal of Internal Medicine 2002; 251: 278-279
34. Wyss M, Daouk RK. Creatine and Creatinine Metabolism. Massachusetts.
Physiological Reviews Vol. 80, No. 3, July 2000: 1114
35. Khan FY, Sayed H. Rhabdomyolysis associated with Mycoplasma
pneumoniae pneumonia. Doha, Qatar. Hong Kong Med J Vol 18 No 3, June
2012: 247-248
36. Blanco RJ, Zabalza M, Salcedo J, Roman SJ. Rhabdomyolysis as a results of
Streptococcus pneumoniae: report of a case and review. Spain. European
Society of Clinical Microbiology and Infectious Diseases 2003 : 944-947
37. Mortron SE, Mathai M, Byrd RP, Fields CL, Toy TM. Influenza a Pneumonia
with Rhabdomyolysis. Johnson City. South Med J. 2001; 94 (1)
38. Garcia MC, Ebeo CT, Byrd RP Jr, Roy TM. Rhabdomyolysis associated with
pneumococcal pneumonia: an early clinical indicator of increased morbidity?.
Mountain Home. Tenn Med 2002 Feb; 95(2): 67-9.
39. Ali A, El S, Sikka P, Ramadan F, Davies J. Etiology of Severe Pneumonia in
the Very Elderly. American Journal of Respiratory and Critical Care
Medicine, Vol. 163, No. 3 (2001), pp. 645-651
 52

LAMPIRAN

Lampiran 1. Biodata Penulis

1. Identitas

Nama : Stefanus Christian Setiawan

NIM : 22010111120009

Tempat/tanggal lahir : Semarang, 18 Desember 1993

Jenis kelamin : Laki-Laki

Alamat : Jl. Kenconowungu 6 / 37, Semarang

Nomor HP : 081227007702

E-mail : stchristians@yahoo.com

2. Riwayat Pendidikan Formal

1. SD : SD YSKI Lulus tahun : 2005

2. SMP : SMP Domenico Savio Lulus Tahun : 2008

3. SMA : SMA Karangturi Lulus Tahun : 2011

4. FK UNDIP : Masuk Tahun 2011

3. Keanggotaan Organisasi

1. Sie. Perkap Porseni FK UNDIP 2013

2. Sie. P&K PMKK FK UNDIP 2011-2012

3. Wakil Ketua Kemah Bakti FK UNDIP 2014

 53

Lampiran 2. Ethical Clearance

 54

Lampiran 3. Kuisioner CAPSIN

 55

Lampiran 4. Analisis Data SPSS

Crosstabs

Jenis kelamin * Outcome

Crosstab

Outcome
Mati Sembuh Total
Jenis kelamin P Count 17 43 60
% within Jenis kelamin 28.3% 71.7% 100.0%
W Count 21 52 73
% within Jenis kelamin 28.8% 71.2% 100.0%
Total Count 38 95 133
% within Jenis kelamin 28.6% 71.4% 100.0%

Usia * Outcome
Crosstab

Outcome
Mati Sembuh Total
Usia 15-24 Count 0 10 10
% within Usia .0% 100.0% 100.0%
25-34 Count 3 5 8
% within Usia 37.5% 62.5% 100.0%
35-44 Count 4 14 18
% within Usia 22.2% 77.8% 100.0%
45-54 Count 7 15 22
% within Usia 31.8% 68.2% 100.0%
55-64 Count 11 18 29
% within Usia 37.9% 62.1% 100.0%
>= 65 Count 13 33 46
% within Usia 28.3% 71.7% 100.0%
Total Count 38 95 133
% within Usia 28.6% 71.4% 100.0%
 56

Demam * Outcome
Crosstab

Outcome
Mati Sembuh Total
Demam Ya Count 34 83 117
% within Demam 29.1% 70.9% 100.0%
Tidak Count 4 12 16
% within Demam 25.0% 75.0% 100.0%
Total Count 38 95 133
% within Demam 28.6% 71.4% 100.0%

Chi-Square Tests

Asymp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square .114b 1 .736
Continuity Correctiona .002 1 .966
Likelihood Ratio .116 1 .733
Fisher's Exact Test 1.000 .497
Linear-by-Linear
.113 1 .737
Association
N of Valid Cases 133
a. Computed only for a 2x2 table
b. 1 cells (25.0%) have expected count less than 5. The minimum expected count is
4.57.

Risk Estimate

95% Confidence
Interval
Value Lower Upper
Odds Ratio for
1.229 .370 4.080
Demam (Ya / Tidak)
For cohort Outcome
1.162 .475 2.844
= Mati
For cohort Outcome
.946 .697 1.284
= Sembuh
N of Valid Cases 133
 57

Sakit kepala * Outcome

Crosstab

Outcome
Mati Sembuh Total
Sakit kepala Ya Count 9 29 38
% within Sakit kepala 23.7% 76.3% 100.0%
Tidak Count 29 66 95
% within Sakit kepala 30.5% 69.5% 100.0%
Total Count 38 95 133
% within Sakit kepala 28.6% 71.4% 100.0%

Chi-Square Tests

Asymp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square .623b 1 .430
Continuity Correctiona .333 1 .564
Likelihood Ratio .637 1 .425
Fisher's Exact Test .526 .285
Linear-by-Linear
.618 1 .432
Association
N of Valid Cases 133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
10.86.

Risk Estimate

95% Confidence
Interval
Value Lower Upper
Odds Ratio for Sakit
.706 .297 1.679
kepala (Ya / Tidak)
For cohort Outcome
.776 .407 1.481
= Mati
For cohort Outcome
1.098 .880 1.371
= Sembuh
N of Valid Cases 133
 58

Chill * Outcome
Crosstab

Outcome
Mati Sembuh Total
Chill Ya Count 7 21 28
% within Chill 25.0% 75.0% 100.0%
Tidak Count 31 74 105
% within Chill 29.5% 70.5% 100.0%
Total Count 38 95 133
% within Chill 28.6% 71.4% 100.0%

Chi-Square Tests

Asymp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square .222b 1 .638
Continuity Correctiona .055 1 .814
Likelihood Ratio .226 1 .634
Fisher's Exact Test .814 .415
Linear-by-Linear
.220 1 .639
Association
N of Valid Cases 133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
8.00.

Risk Estimate

95% Confidence
Interval
Value Lower Upper
Odds Ratio for Chill
.796 .307 2.063
(Ya / Tidak)
For cohort Outcome
.847 .418 1.716
= Mati
For cohort Outcome
1.064 .831 1.362
= Sembuh
N of Valid Cases 133
 59

Batuk * Outcome
Crosstab

Outcome
Mati Sembuh Total
Batuk Ya Count 36 89 125
% within Batuk 28.8% 71.2% 100.0%
Tidak Count 2 6 8
% within Batuk 25.0% 75.0% 100.0%
Total Count 38 95 133
% within Batuk 28.6% 71.4% 100.0%

Chi-Square Tests

Asymp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square .053b 1 .818
Continuity Correctiona .000 1 1.000
Likelihood Ratio .055 1 .815
Fisher's Exact Test 1.000 .588
Linear-by-Linear
.053 1 .818
Association
N of Valid Cases 133
a. Computed only for a 2x2 table
b. 1 cells (25.0%) have expected count less than 5. The minimum expected count is
2.29.

Risk Estimate

95% Confidence
Interval
Value Lower Upper
Odds Ratio for
1.213 .234 6.296
Batuk (Ya / Tidak)
For cohort Outcome
1.152 .336 3.947
= Mati
For cohort Outcome
.949 .627 1.438
= Sembuh
N of Valid Cases 133
 60

Sputum * Outcome
Crosstab

Outcome
Mati Sembuh Total
Sputum Ya Count 25 66 91
% within Sputum 27.5% 72.5% 100.0%
Tidak Count 13 29 42
% within Sputum 31.0% 69.0% 100.0%
Total Count 38 95 133
% within Sputum 28.6% 71.4% 100.0%

Chi-Square Tests

Asymp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square .171b 1 .680
Continuity Correctiona .043 1 .836
Likelihood Ratio .169 1 .681
Fisher's Exact Test .685 .414
Linear-by-Linear
.169 1 .681
Association
N of Valid Cases 133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
12.00.

Risk Estimate

95% Confidence
Interval
Value Lower Upper
Odds Ratio for
.845 .380 1.880
Sputum (Ya / Tidak)
For cohort Outcome
.888 .506 1.556
= Mati
For cohort Outcome
1.050 .827 1.334
= Sembuh
N of Valid Cases 133
 61

Hemoptysis * Outcome
Crosstab

Outcome
Mati Sembuh Total
Hemoptysis Ya Count 0 12 12
% within Hemoptysis .0% 100.0% 100.0%
Tidak Count 38 83 121
% within Hemoptysis 31.4% 68.6% 100.0%
Total Count 38 95 133
% within Hemoptysis 28.6% 71.4% 100.0%

Chi-Square Tests

Asymp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square 5.276 b 1 .022
Continuity Correctiona 3.849 1 .050
Likelihood Ratio 8.542 1 .003
Fisher's Exact Test .019 .014
Linear-by-Linear
5.236 1 .022
Association
N of Valid Cases 133
a. Computed only for a 2x2 table
b. 1 cells (25.0%) have expected count less than 5. The minimum expected count is
3.43.

Risk Estimate

95% Confidence
Interval
Value Lower Upper
For cohort Outcome
1.458 1.292 1.645
= Sembuh
N of Valid Cases 133

Dyspnea * Outcome
 62

Crosstab

Outcome
Mati Sembuh Total
Dyspnea Ya Count 38 80 118
% within Dyspnea 32.2% 67.8% 100.0%
Tidak Count 0 15 15
% within Dyspnea .0% 100.0% 100.0%
Total Count 38 95 133
% within Dyspnea 28.6% 71.4% 100.0%

Chi-Square Tests

Asymp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square 6.763 b 1 .009
Continuity Correctiona 5.277 1 .022
Likelihood Ratio 10.839 1 .001
Fisher's Exact Test .006 .005
Linear-by-Linear
6.712 1 .010
Association
N of Valid Cases 133
a. Computed only for a 2x2 table
b. 1 cells (25.0%) have expected count less than 5. The minimum expected count is
4.29.

Risk Estimate

95% Confidence
Interval
Value Lower Upper
For cohort Outcome
.678 .599 .768
= Sembuh
N of Valid Cases 133

Pleuric pain * Outcome

Crosstab

Outcome
Mati Sembuh Total
Pleuric Ya Count 1 6 7
pain % within Pleuric pain 14.3% 85.7% 100.0%
Tidak Count 37 89 126
% within Pleuric pain 29.4% 70.6% 100.0%
Total Count 38 95 133
% within Pleuric pain 28.6% 71.4% 100.0%
 63

Chi-Square Tests

Asymp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square .739b 1 .390
Continuity Correctiona .185 1 .667
Likelihood Ratio .840 1 .359
Fisher's Exact Test .673 .354
Linear-by-Linear
.733 1 .392
Association
N of Valid Cases 133
a. Computed only for a 2x2 table
b. 1 cells (25.0%) have expected count less than 5. The minimum expected count is
2.00.

Risk Estimate

95% Confidence
Interval
Value Lower Upper
Odds Ratio for Pleuric
.401 .047 3.447
pain (Ya / Tidak)
For cohort Outcome =
.486 .078 3.047
Mati
For cohort Outcome =
1.213 .879 1.676
Sembuh
N of Valid Cases 133

Penurunan kesadaran * Outcome

Crosstab

Outcome
Mati Sembuh Total
Penurunan Ya Count 17 10 27
kesadaran % within Penurunan
63.0% 37.0% 100.0%
kesadaran
Tidak Count 21 85 106
% within Penurunan
19.8% 80.2% 100.0%
kesadaran
Total Count 38 95 133
% within Penurunan
28.6% 71.4% 100.0%
kesadaran
 64

Chi-Square Tests

Asymp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square 19.634b 1 .000
Continuity Correctiona 17.576 1 .000
Likelihood Ratio 18.017 1 .000
Fisher's Exact Test .000 .000
Linear-by-Linear
19.486 1 .000
Association
N of Valid Cases 133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
7.71.

Risk Estimate

95% Confidence
Interval
Value Lower Upper
Odds Ratio for
Penurunan kesadaran 6.881 2.754 17.190
(Ya / Tidak)
For cohort Outcome =
3.178 1.967 5.136
Mati
For cohort Outcome =
.462 .280 .762
Sembuh
N of Valid Cases 133

Profil klinik * Outcome

Crosstab

Outcome
Mati Sembuh Total
Profil 1-3 Count 7 25 32
klinik % within Profil klinik 21.9% 78.1% 100.0%
4-6 Count 31 68 99
% within Profil klinik 31.3% 68.7% 100.0%
6-9 Count 0 2 2
% within Profil klinik .0% 100.0% 100.0%
Total Count 38 95 133
% within Profil klinik 28.6% 71.4% 100.0%
 65

Chi-Square Tests

Asymp. Sig.
Value df (2-sided)
Pearson Chi-Square 1.868 a 2 .393
Likelihood Ratio 2.446 2 .294
Linear-by-Linear
.441 1 .507
Association
N of Valid Cases 133
a. 2 cells (33.3%) have expected count less than 5. The
minimum expected count is .57.

Hemoglobin * Outcome
Crosstab

Outcome
Mati Sembuh Total
Hemoglobin Tidak Count 25 66 91
% within Hemoglobin 27.5% 72.5% 100.0%
Normal Count 13 29 42
% within Hemoglobin 31.0% 69.0% 100.0%
Total Count 38 95 133
% within Hemoglobin 28.6% 71.4% 100.0%

Chi-Square Tests

Asymp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square .171b 1 .680
Continuity Correctiona .043 1 .836
Likelihood Ratio .169 1 .681
Fisher's Exact Test .685 .414
Linear-by-Linear
.169 1 .681
Association
N of Valid Cases 133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
12.00.
 66

Risk Estimate

95% Confidence
Interval
Value Lower Upper
Odds Ratio for
Hemoglobin (Tidak / .845 .380 1.880
Normal)
For cohort Outcome
.888 .506 1.556
= Mati
For cohort Outcome
1.050 .827 1.334
= Sembuh
N of Valid Cases 133

Hematokrit * Outcome
Crosstab

Outcome
Mati Sembuh Total
Hematokrit Tidak Count 24 61 85
% within Hematokrit 28.2% 71.8% 100.0%
Normal Count 14 34 48
% within Hematokrit 29.2% 70.8% 100.0%
Total Count 38 95 133
% within Hematokrit 28.6% 71.4% 100.0%

Chi-Square Tests

Asymp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square .013b 1 .909
Continuity Correctiona .000 1 1.000
Likelihood Ratio .013 1 .909
Fisher's Exact Test 1.000 .531
Linear-by-Linear
.013 1 .909
Association
N of Valid Cases 133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
13.71.
 67

Risk Estimate

95% Confidence
Interval
Value Lower Upper
Odds Ratio for Hematokrit
.956 .437 2.087
(Tidak / Normal)
For cohort Outcome = Mati
.968 .555 1.688
For cohort Outcome =
1.013 .809 1.269
Sembuh
N of Valid Cases 133

Eritrosit * Outcome
Crosstab

Outcome
Mati Sembuh Total
Eritrosit Tidak Count 18 54 72
% within Eritrosit 25.0% 75.0% 100.0%
Normal Count 20 33 53
% within Eritrosit 37.7% 62.3% 100.0%
Total Count 38 87 125
% within Eritrosit 30.4% 69.6% 100.0%

Chi-Square Tests

Asymp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square 2.340 b 1 .126
Continuity Correctiona 1.777 1 .183
Likelihood Ratio 2.325 1 .127
Fisher's Exact Test .168 .092
Linear-by-Linear
2.322 1 .128
Association
N of Valid Cases 125
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
16.11.
 68

Risk Estimate

95% Confidence
Interval
Value Lower Upper
Odds Ratio for Eritrosit
.550 .255 1.188
(Tidak / Normal)
For cohort Outcome =
.663 .390 1.124
Mati
For cohort Outcome =
1.205 .940 1.544
Sembuh
N of Valid Cases 125

Lekosit * Outcome
Crosstab

Outcome
Mati Sembuh Total
Lekosit Tidak Count 26 67 93
% within Lekosit 28.0% 72.0% 100.0%
Normal Count 12 28 40
% within Lekosit 30.0% 70.0% 100.0%
Total Count 38 95 133
% within Lekosit 28.6% 71.4% 100.0%

Chi-Square Tests

Asymp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square .057b 1 .811
Continuity Correctiona .001 1 .976
Likelihood Ratio .057 1 .811
Fisher's Exact Test .836 .483
Linear-by-Linear
.057 1 .812
Association
N of Valid Cases 133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
11.43.
 69

Risk Estimate

95% Confidence
Interval
Value Lower Upper
Odds Ratio for Lekosit
.905 .401 2.043
(Tidak / Normal)
For cohort Outcome =
.932 .524 1.656
Mati
For cohort Outcome =
1.029 .810 1.307
Sembuh
N of Valid Cases 133

Trombosit * Outcome
Crosstab

Outcome
Mati Sembuh Total
Trombosit Tidak Count 20 44 64
% within Trombosit 31.3% 68.8% 100.0%
Normal Count 18 51 69
% within Trombosit 26.1% 73.9% 100.0%
Total Count 38 95 133
% within Trombosit 28.6% 71.4% 100.0%

Chi-Square Tests

Asymp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square .434b 1 .510
Continuity Correctiona .218 1 .641
Likelihood Ratio .434 1 .510
Fisher's Exact Test .567 .320
Linear-by-Linear
.430 1 .512
Association
N of Valid Cases 133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
18.29.
 70

Risk Estimate

95% Confidence
Interval
Value Lower Upper
Odds Ratio for Trombosit
1.288 .606 2.737
(Tidak / Normal)
For cohort Outcome = Mati
1.198 .699 2.052
For cohort Outcome =
.930 .749 1.155
Sembuh
N of Valid Cases 133

Ureum * Outcome
Crosstab

Outcome
Mati Sembuh Total
Ureum Tidak Count 28 57 85
% within Ureum 32.9% 67.1% 100.0%
Normal Count 10 38 48
% within Ureum 20.8% 79.2% 100.0%
Total Count 38 95 133
% within Ureum 28.6% 71.4% 100.0%

Chi-Square Tests

Asymp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square 2.204 b 1 .138
Continuity Correctiona 1.650 1 .199
Likelihood Ratio 2.273 1 .132
Fisher's Exact Test .164 .098
Linear-by-Linear
2.187 1 .139
Association
N of Valid Cases 133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
13.71.
 71

Risk Estimate

95% Confidence
Interval
Value Lower Upper
Odds Ratio for Ureum
1.867 .814 4.283
(Tidak / Normal)
For cohort Outcome =
1.581 .843 2.967
Mati
For cohort Outcome =
.847 .688 1.043
Sembuh
N of Valid Cases 133

Kreatinin * Outcome
Crosstab

Outcome
Mati Sembuh Total
Kreatinin Tidak Count 21 26 47
% within Kreatinin 44.7% 55.3% 100.0%
Normal Count 17 69 86
% within Kreatinin 19.8% 80.2% 100.0%
Total Count 38 95 133
% within Kreatinin 28.6% 71.4% 100.0%

Chi-Square Tests

Asymp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square 9.243 b 1 .002
Continuity Correctiona 8.062 1 .005
Likelihood Ratio 9.005 1 .003
Fisher's Exact Test .004 .002
Linear-by-Linear
9.173 1 .002
Association
N of Valid Cases 133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
13.43.
 72

Risk Estimate

95% Confidence
Interval
Value Lower Upper
Odds Ratio for Kreatinin
3.278 1.499 7.169
(Tidak / Normal)
For cohort Outcome =
2.260 1.328 3.846
Mati
For cohort Outcome =
.689 .522 .910
Sembuh
N of Valid Cases 133

GD sewaktu * Outcome
Crosstab

Outcome
Mati Sembuh Total
GD sewaktu Tidak Count 12 38 50
% within GD sewaktu 24.0% 76.0% 100.0%
Normal Count 26 57 83
% within GD sewaktu 31.3% 68.7% 100.0%
Total Count 38 95 133
% within GD sewaktu 28.6% 71.4% 100.0%

Chi-Square Tests

Asymp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square .820b 1 .365
Continuity Correctiona .501 1 .479
Likelihood Ratio .833 1 .361
Fisher's Exact Test .431 .241
Linear-by-Linear
.814 1 .367
Association
N of Valid Cases 133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
14.29.
 73

Risk Estimate

95% Confidence
Interval
Value Lower Upper
Odds Ratio for GD
.692 .312 1.537
sewaktu (Tidak / Normal)
For cohort Outcome = Mati
.766 .426 1.378
For cohort Outcome =
1.107 .894 1.369
Sembuh
N of Valid Cases 133

Natrium * Outcome
Crosstab

Outcome
Mati Sembuh Total
Natrium Tidak Count 21 46 67
% within Natrium 31.3% 68.7% 100.0%
Normal Count 17 49 66
% within Natrium 25.8% 74.2% 100.0%
Total Count 38 95 133
% within Natrium 28.6% 71.4% 100.0%

Chi-Square Tests

Asymp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square .508b 1 .476
Continuity Correctiona .271 1 .602
Likelihood Ratio .509 1 .476
Fisher's Exact Test .566 .301
Linear-by-Linear
.504 1 .478
Association
N of Valid Cases 133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
18.86.
 74

Risk Estimate

95% Confidence
Interval
Value Lower Upper
Odds Ratio for Natrium
1.316 .618 2.801
(Tidak / Normal)
For cohort Outcome =
1.217 .708 2.092
Mati
For cohort Outcome =
.925 .746 1.147
Sembuh
N of Valid Cases 133

Kalium * Outcome
Crosstab

Outcome
Mati Sembuh Total
Kalium Tidak Count 13 42 55
% within Kalium 23.6% 76.4% 100.0%
Normal Count 25 53 78
% within Kalium 32.1% 67.9% 100.0%
Total Count 38 95 133
% within Kalium 28.6% 71.4% 100.0%

Chi-Square Tests

Asymp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square 1.119 b 1 .290
Continuity Correctiona .745 1 .388
Likelihood Ratio 1.134 1 .287
Fisher's Exact Test .333 .195
Linear-by-Linear
1.111 1 .292
Association
N of Valid Cases 133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
15.71.
 75

Risk Estimate

95% Confidence
Interval
Value Lower Upper
Odds Ratio for Kalium
.656 .300 1.436
(Tidak / Normal)
For cohort Outcome =
.737 .415 1.310
Mati
For cohort Outcome =
1.124 .909 1.389
Sembuh
N of Valid Cases 133

Khlorida * Outcome
Crosstab

Outcome
Mati Sembuh Total
Khlorida Tidak Count 21 32 53
% within Khlorida 39.6% 60.4% 100.0%
Normal Count 17 63 80
% within Khlorida 21.3% 78.8% 100.0%
Total Count 38 95 133
% within Khlorida 28.6% 71.4% 100.0%

Chi-Square Tests

Asymp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square 5.273 b 1 .022
Continuity Correctiona 4.411 1 .036
Likelihood Ratio 5.206 1 .023
Fisher's Exact Test .031 .018
Linear-by-Linear
5.233 1 .022
Association
N of Valid Cases 133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
15.14.
 76

Risk Estimate

95% Confidence
Interval
Value Lower Upper
Odds Ratio for Khlorida
2.432 1.128 5.242
(Tidak / Normal)
For cohort Outcome =
1.865 1.090 3.190
Mati
For cohort Outcome =
.767 .599 .981
Sembuh
N of Valid Cases 133

Kalsium * Outcome
Crosstab

Outcome
Mati Sembuh Total
Kalsium Tidak Count 16 41 57
% within Kalsium 28.1% 71.9% 100.0%
Normal Count 15 34 49
% within Kalsium 30.6% 69.4% 100.0%
Total Count 31 75 106
% within Kalsium 29.2% 70.8% 100.0%

Chi-Square Tests

Asymp. Sig. Exact Sig. Exact Sig.

Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square .082b 1 .774
Continuity Correctiona .005 1 .942
Likelihood Ratio .082 1 .774
Fisher's Exact Test .832 .470
Linear-by-Linear
.082 1 .775
Association
N of Valid Cases 106
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
14.33.
 77

Risk Estimate

95% Confidence
Interval
Value Lower Upper
Odds Ratio for Kalsium
.885 .382 2.046
(Tidak / Normal)
For cohort Outcome =
.917 .507 1.657
Mati
For cohort Outcome =
1.037 .810 1.327
Sembuh
N of Valid Cases 106

Logistic Regression
Case Processing Summary
a
Unweighted Cases N Percent
Selected Cases Included in Analysis 133 100.0
Missing Cases 0 .0
Total 133 100.0
Unselected Cases 0 .0
Total 133 100.0
a. If weight is in effect, see classification table for the total
number of cases.
 78

Dependent Variable Encoding

Original Value Internal Value

Sembuh 0
Mati 1

Categorical Variables Codings

Paramete
Frequency r coding
(1)
Khlorida Tidak 53 .000
Normal 80 1.000
Dyspnea Ya 118 .000
Tidak 15 1.000
Penurunan Ya 27 .000
kesadaran Tidak 106 1.000
Kreatinin Tidak 47 .000
Normal 86 1.000
Hemoptysis Ya 12 .000
Tidak 121 1.000

Block 0: Beginning Block

Classification Tablea,b

Predicted

Outcome Percentage
Observed Sembuh Mati Correct
Step 0 Outcome Sembuh 95 0 100.0
Mati 38 0 .0
Overall Percentage 71.4
a. Constant is included in the model.
b. The cut value is .500

Variables in the Equation

B S.E. Wald df Sig. Exp(B)

Step 0 Constant -.916 .192 22.789 1 .000 .400
 79

Variables not in the Equation

Score df Sig.
Step Variables HEMOP(1) 5.276 1 .022
0 DYSP(1) 6.763 1 .009
TK(1) 19.634 1 .000
KREAT(1) 9.243 1 .002
CHLR(1) 5.273 1 .022
Overall Statistics 33.940 5 .000

Block 1: Method = Enter

Omnibus Tests of Model Coefficients

Chi-square df Sig.
Step 1 Step 41.355 5 .000
Block 41.355 5 .000
Model 41.355 5 .000

Model Summary

-2 Log Cox & Snell Nagelkerke

Step likelihood R Square R Square
1 117.784 .267 .383

Classification Tablea

Predicted

Outcome Percentage
Observed Sembuh Mati Correct
Step 1 Outcome Sembuh 88 7 92.6
Mati 26 12 31.6
Overall Percentage 75.2
a. The cut value is .500

Variables in the Equation

95.0% C.I.for
EXP(B)
B S.E. Wald df Sig. Exp(B) Lower Upper
Step
a HEMOP(1) 20.094 10479.2 .000 1 .998 5.E+08 .000 .
1 DYSP(1) -20.128 9659.54 .000 1 .998 .000 .000 .
TK(1) -1.646 .522 9.924 1 .002 .193 .069 .537
KREAT(1) -1.106 .459 5.810 1 .016 .331 .135 .813
CHLR(1) -.554 .457 1.466 1 .226 .575 .235 1.409
Constant -18.511 10479.2 .000 1 .999 .000
a. Variable(s) entered on step 1: HEMOP, DYSP, TK, KREAT, CHLR.
 80

Logistic Regression
Case Processing Summary
a
Unweighted Cases N Percent
Selected Cases Included in Analysis 133 100.0
Missing Cases 0 .0
Total 133 100.0
Unselected Cases 0 .0
Total 133 100.0
a. If weight is in effect, see classification table for the total
number of cases.

Dependent Variable Encoding

Original Value Internal Value

Sembuh 0
Mati 1

Categorical Variables Codings

Paramete
Frequency r coding
(1)
Kreatinin Tidak 47 .000
Normal 86 1.000
Penurunan Ya 27 .000
kesadaran Tidak 106 1.000

Block 0: Beginning Block

 81

Classification Tablea,b

Predicted

Outcome Percentage
Observed Sembuh Mati Correct
Step 0 Outcome Sembuh 95 0 100.0
Mati 38 0 .0
Overall Percentage 71.4
a. Constant is included in the model.
b. The cut value is .500

Variables in the Equation

B S.E. Wald df Sig. Exp(B)

Step 0 Constant -.916 .192 22.789 1 .000 .400

Variables not in the Equation

Score df Sig.
Step Variables TK(1) 19.634 1 .000
0 KREAT(1) 9.243 1 .002
Overall Statistics 24.938 2 .000

Block 1: Method = Enter

Omnibus Tests of Model Coefficients

Chi-square df Sig.
Step 1 Step 23.951 2 .000
Block 23.951 2 .000
Model 23.951 2 .000

Model Summary

-2 Log Cox & Snell Nagelkerke

Step likelihood R Square R Square
1 135.188 .165 .236

Classification Tablea

Predicted

Outcome Percentage
Observed Sembuh Mati Correct
Step 1 Outcome Sembuh 85 10 89.5
Mati 21 17 44.7
Overall Percentage 76.7
a. The cut value is .500
 82

Variables in the Equation

95.0% C.I.for EXP(B)

B S.E. Wald df Sig. Exp(B) Lower Upper
Step
a TK(1) -1.818 .481 14.306 1 .000 .162 .063 .416
1 KREAT(1) -1.042 .428 5.918 1 .015 .353 .152 .817
Constant 1.068 .474 5.077 1 .024 2.908
a. Variable(s) entered on step 1: TK, KREAT.